Professional Summary »
Specializing In »
Practice Locations »
Specializing In
- Pathology
Professional Summary
Education & Certifications
- Board Certification: American Osteopathic Board of Pathology, Hematopathology (2022)
- Residency: Stanford University Pathology Residency (2016) CA
- Medical Education: University of Michigan School of Medicine (2007) MI
- Residency: Stanford University Pathology Residency (2011) CA
- Fellowship: Stanford University Hemapathology Fellowship (2010) CA
- Board Certification: American Board of Pathology, Clinical Pathology (2016)
- American Board of Pathology, Clinical Pathology (2016)
- Residency, Stanford Health Care, Clinical Pathology (2016)
- Board Certification: American Board of Pathology, Anatomic Pathology (2011)
- Residency, Stanford Health Care, Anatomic Pathology (2011)
- Fellowship, Stanford Health Care, Hematopathology (2010)
Administrative Appointments
- Laboratory Director, Stanford Health Care, Emeryville (2016 - Present)
- Section Director, Clinical Hematology Laboratory, Stanford (2016 - Present)
Publications
-
Tyrosine 813 is a site of JAK2 autophosphorylation critical for activation of JAK2 by SH2-B beta
Kurzer, J. H., Argetsinger, L. S., Zhou, Y. J., Kouadio, J. L., O'Shea, J. J., & Carter-Su, C. (2004). Tyrosine 813 is a site of JAK2 autophosphorylation critical for activation of JAK2 by SH2-B beta. MOLECULAR AND CELLULAR BIOLOGY, 24(10), 4557–4570. -
Capillary electrophoresis and fluorescence anisotropy for quantitative analysis of peptide-protein interactions using JAK2 and SH2-B beta as a model system
Yang, P. L., Whelan, R. J., Jameson, E. E., Kurzer, J. H., Argetsinger, L. S., Carter-Su, C., … Kennedy, R. T. (2005). Capillary electrophoresis and fluorescence anisotropy for quantitative analysis of peptide-protein interactions using JAK2 and SH2-B beta as a model system. ANALYTICAL CHEMISTRY, 77(8), 2482–2489. -
Binding of SH2-B family members within a potential negative regulatory region maintains JAK2 in an active state
Kurzer, J. H., Saharinen, P., Silvennoinen, O., & Carter-Su, C. (2006). Binding of SH2-B family members within a potential negative regulatory region maintains JAK2 in an active state. MOLECULAR AND CELLULAR BIOLOGY, 26(17), 6381–6394. -
SH2B1 (SH2-B) and JAK2: a multifunctional adaptor protein and kinase made for each other
Maures, T. J., Kurzer, J. H., & Carter-Su, C. (2007). SH2B1 (SH2-B) and JAK2: a multifunctional adaptor protein and kinase made for each other. TRENDS IN ENDOCRINOLOGY AND METABOLISM, 18(1), 38–45. -
Mesenchymal stromal cell density is increased in higher grade myelodysplastic syndromes and independently predicts survival.
Johnson, R. C., Kurzer, J. H., Greenberg, P. L., & Gratzinger, D. (2014). Mesenchymal stromal cell density is increased in higher grade myelodysplastic syndromes and independently predicts survival. American Journal of Clinical Pathology, 142(6), 795–802. -
A replicable CD271+ mesenchymal stromal cell density score: bringing the dysfunctional myelodysplastic syndrome niche to the diagnostic laboratory.
Gars, E., Yousry, S. M., Babu, D., Kurzer, J. H., George, T. I., & Gratzinger, D. (2016). A replicable CD271+ mesenchymal stromal cell density score: bringing the dysfunctional myelodysplastic syndrome niche to the diagnostic laboratory. Leukemia & Lymphoma, 1–3. -
E2A-PBX1 remodels oncogenic signaling networks in B-cell precursor acute lymphoid leukemia.
Duque-Afonso, J., Lin, C.-H., Han, K., Wei, M. C., Feng, J., Kurzer, J., … Cleary, M. L. (2016). E2A-PBX1 remodels oncogenic signaling networks in B-cell precursor acute lymphoid leukemia. Cancer Research. -
SETDB2 Links E2A-PBX1 to Cell-Cycle Dysregulation in Acute Leukemia through CDKN2C Repression.
Lin, C.-H., Wong, S. H.-K., Kurzer, J. H., Schneidawind, C., Wei, M. C., Duque-Afonso, J., … Cleary, M. L. (2018). SETDB2 Links E2A-PBX1 to Cell-Cycle Dysregulation in Acute Leukemia through CDKN2C Repression. Cell Reports, 23(4), 1166–77. -
Identification of early B cell precursors (stage 1 and 2 hematogones) in the peripheral blood.
Kurzer, J. H., & Weinberg, O. K. (2018). Identification of early B cell precursors (stage 1 and 2 hematogones) in the peripheral blood. Journal of Clinical Pathology. -
Identification of Early Hematogones in the Peripheral Blood
Kurzer, J. H., & Weinberg, O. K. (2018). Identification of Early Hematogones in the Peripheral Blood. MODERN PATHOLOGY, 31, 530. -
Flow Immunophenotyping of Benign Lymph Nodes Sampled by FNA: Representative With Diagnostic Pitfalls.
Scott, G. D., Lau, H. D., Kurzer, J. H., Kong, C. S., & Gratzinger, D. A. (2018). Flow Immunophenotyping of Benign Lymph Nodes Sampled by FNA: Representative With Diagnostic Pitfalls. Cancer Cytopathology. -
Clinical, Immunophenotypic and Genomic Findings of Acute Undifferentiated Leukemia and Comparison to AML with Minimal Differentiation: A Study from the Bone Marrow Pathology Group
Weinberg, O. K., Hasserjian, R. P., Baraban, E., Ok, C. Y., Geyer, J. T., Philip, J. K. S. S., … Arber, D. A. (2018). Clinical, Immunophenotypic and Genomic Findings of Acute Undifferentiated Leukemia and Comparison to AML with Minimal Differentiation: A Study from the Bone Marrow Pathology Group. BLOOD, 132. -
Impact of Pre-Transplant Donor BK Viruria in Kidney Transplant Recipients.
Tan, S. K., Huang, C. H., Sahoo, M. K., Weber, J., Kurzer, J., Stedman, M. R., … Pinsky, B. A. (2019). Impact of Pre-Transplant Donor BK Viruria in Kidney Transplant Recipients. The Journal of Infectious Diseases. -
Clinical, immunophenotypic, and genomic findings of acute undifferentiated leukemia and comparison to acute myeloid leukemia with minimal differentiation: a study from the bone marrow pathology group.
Weinberg, O. K., Hasserjian, R. P., Baraban, E., Ok, C. Y., Geyer, J. T., Philip, J. K., … Arber, D. A. (2019). Clinical, immunophenotypic, and genomic findings of acute undifferentiated leukemia and comparison to acute myeloid leukemia with minimal differentiation: a study from the bone marrow pathology group. Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc. -
Acute Leukemias of Ambiguous Lineage: Clarification on Lineage Specificity.
Kurzer, J. H., & Weinberg, O. K. (2019). Acute Leukemias of Ambiguous Lineage: Clarification on Lineage Specificity. Surgical Pathology Clinics, 12(3), 687–97. -
Impact of Pretransplant Donor BK Viruria in Kidney Transplant Recipients
Tan, S. K., Huang, C. H., Sahoo, M. K., Weber, J., Kurzer, J., Stedman, M. R., … Pinsky, B. A. (2019). Impact of Pretransplant Donor BK Viruria in Kidney Transplant Recipients. JOURNAL OF INFECTIOUS DISEASES, 220(3), 370–76. -
Rationale and Feasibility of Using a Standardized Screening Tube on the FACSCanto II and the FACSLyric
Jackson, R., Oak, J., & Kurzer, J. (2019). Rationale and Feasibility of Using a Standardized Screening Tube on the FACSCanto II and the FACSLyric. LABORATORY INVESTIGATION, 99. -
Rationale and Feasibility of Using a Standardized Screening Tube on the FACSCanto II and the FACSLyric
Jackson, R., Oak, J., & Kurzer, J. (2019). Rationale and Feasibility of Using a Standardized Screening Tube on the FACSCanto II and the FACSLyric. MODERN PATHOLOGY. NATURE PUBLISHING GROUP. -
Clinical, immunophenotypic, and genomic findings of acute undifferentiated leukemia and comparison to acute myeloid leukemia with minimal differentiation: a study from the bone marrow pathology group
Weinberg, O. K., Hasserjian, R. P., Baraban, E., Ok, C. Y., Geyer, J. T., Philip, J. K. S. S., … Arber, D. A. (2019). Clinical, immunophenotypic, and genomic findings of acute undifferentiated leukemia and comparison to acute myeloid leukemia with minimal differentiation: a study from the bone marrow pathology group. MODERN PATHOLOGY, 32(9), 1373–85. -
Clinical and Genomic Characterization of Myeloproliferative Neoplasms Harboring PHF6 Mutations
Kurzer, J., Nardi, V., Ouseph, M., & Weinberg, O. (2020). Clinical and Genomic Characterization of Myeloproliferative Neoplasms Harboring PHF6 Mutations. LABORATORY INVESTIGATION. NATURE PUBLISHING GROUP. -
Clinical and Genomic Characterization of Myeloproliferative Neoplasms Harboring PHF6 Mutations
Kurzer, J., Nardi, V., Ouseph, M., & Weinberg, O. (2020). Clinical and Genomic Characterization of Myeloproliferative Neoplasms Harboring PHF6 Mutations. MODERN PATHOLOGY. NATURE PUBLISHING GROUP. -
Comparison of a Point-of-Care Assay and a High-Complexity Assay for Detection of SARS-CoV-2 RNA.
Stevens, B., Hogan, C. A., Sahoo, M. K., Huang, C. H., Garamani, N., Zehnder, J., … Pinsky, B. A. (2020). Comparison of a Point-of-Care Assay and a High-Complexity Assay for Detection of SARS-CoV-2 RNA. The Journal of Applied Laboratory Medicine. -
High Frequency of SARS-CoV-2 RNAemia and Association With Severe Disease.
Hogan, C. A., Stevens, B. A., Sahoo, M. K., Huang, C. H., Garamani, N., Gombar, S., … Pinsky, B. A. (2020). High Frequency of SARS-CoV-2 RNAemia and Association With Severe Disease. Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America. -
Clinical, immunophenotypic and genomic findings of NK lymphoblastic leukemia: a study from the Bone Marrow Pathology Group.
Weinberg, O. K., Chisholm, K. M., Ok, C. Y., Fedoriw, Y., Grzywacz, B., Kurzer, J. H., … Hasserjian, R. P. (2021). Clinical, immunophenotypic and genomic findings of NK lymphoblastic leukemia: a study from the Bone Marrow Pathology Group. Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc. -
Evaluation of a measles virus multiplex, triple-target real-time RT-PCR in three specimen matrices at a U.S. academic medical center.
Broadhurst, M. J., Garamani, N., Hahn, Z., Jiang, B., Weber, J., Huang, C. H., … Pinsky, B. A. (2021). Evaluation of a measles virus multiplex, triple-target real-time RT-PCR in three specimen matrices at a U.S. academic medical center. Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology, 136, 104757. -
Combined SARS-CoV-2 nucleic acid amplification testing and respiratory virus panel RT-PCR on the Hologic Panther Fusion system.
Stevens, B. A., Hogan, C. A., Mfuh, K. O., Khan, G., Sahoo, M. K., Huang, C. H., … Pinsky, B. A. (2021). Combined SARS-CoV-2 nucleic acid amplification testing and respiratory virus panel RT-PCR on the Hologic Panther Fusion system. Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology, 138, 104792. -
PHF6 Mutations in Hematologic Malignancies.
Kurzer, J. H., & Weinberg, O. K. (2021). PHF6 Mutations in Hematologic Malignancies. Frontiers in Oncology, 11, 704471. -
Nonleukemic T/B mixed phenotype acute leukemia with PHF6 and NOTCH1 mutations.
Silva, O., & Kurzer, J. (2021). Nonleukemic T/B mixed phenotype acute leukemia with PHF6 and NOTCH1 mutations. Blood, 138(9), 818. -
Human Germinal Center-associated Lymphoma (HGAL) Is a Reliable Marker of Normal and Neoplastic Follicular Helper T Cells Including Angioimmunoblastic T-Cell Lymphoma.
Koo, M., Zhang, J., Tan, B., Kurzer, J., Gratzinger, D., Zhao, S., … Natkunam, Y. (2021). Human Germinal Center-associated Lymphoma (HGAL) Is a Reliable Marker of Normal and Neoplastic Follicular Helper T Cells Including Angioimmunoblastic T-Cell Lymphoma. The American Journal of Surgical Pathology. -
TP53 mutation defines a unique subgroup within complex karyotype de novo and therapy-related MDS/AML.
Weinberg, O. K., Siddon, A. J., Madanat, Y., Gagan, J., Arber, D. A., Dal Cin, P., … Hasserjian, R. P. (1800). TP53 mutation defines a unique subgroup within complex karyotype de novo and therapy-related MDS/AML. Blood Advances. -
Clinicopathologic and Molecular Analysis of Normal Karyotype Therapy-related and De Novo Acute Myeloid Leukemia: A Multi-institutional Study by the Bone Marrow Pathology Group
Cantu, M., Kanagal-Shamanna, R., Bueso-Ramos, C., Patel, S., Geyer, J., Tam, W., … Weinberg, O. (2022). Clinicopathologic and Molecular Analysis of Normal Karyotype Therapy-related and De Novo Acute Myeloid Leukemia: A Multi-institutional Study by the Bone Marrow Pathology Group. LABORATORY INVESTIGATION. SPRINGERNATURE. -
Flow Cytometry Forward Scatter as a Predictor of Large Cell Transformation in Follicular Lymphoma: A Retrospective Cyto-Heme Inter-Institutional Collaborative (CHIC) study
Menke, J., Wang, L., Xie, Y., Yakubu, R., Balassanian, R., Frank, A., … Gratzinger, D. (2022). Flow Cytometry Forward Scatter as a Predictor of Large Cell Transformation in Follicular Lymphoma: A Retrospective Cyto-Heme Inter-Institutional Collaborative (CHIC) study. MODERN PATHOLOGY. SPRINGERNATURE.
Practice Locations
Stanford Hospital Stanford, CA
Stanford, CA
Stanford Hospital
300 - 500 Pasteur Drive
Stanford , CA 94304
More Clinic Information » Getting Here »Important Information about Our Organizations and Physician Affiliation
Stanford Health Care, Stanford Health Care Tri-Valley, and Stanford Medicine Partners are each independent nonprofit organizations that are affiliated with but separate from each other and from Stanford University. The physicians who provide care at facilities operated by Stanford Health Care, Stanford Health Care Tri-Valley, and Stanford Medicine Partners are faculty, foundation, or community physicians who are not employees, representatives, or agents of Stanford Health Care, Stanford Health Care Tri- Valley, or Stanford Medicine Partners. Stanford Health Care, Stanford Health Care Tri-Valley, and Stanford Medicine Partners do not exercise control over the care provided by such faculty, foundation, and community physicians and are not responsible for their actions.